32.Lin H. Y., Tang H. Y., Shih A., Keating T., Cao G., Davis P. J., Davis F. B. Thyroid hormone is a MAPKdependent growth factor for thyroid cancer cells and is anti-apoptotic // Steroids. 2007. Vol. 72. P. 180–
33.Tang H. Y., Lin H. Y., Zhang S., Davis F. B., Davis P. J. Thyroid hormone causes mitogen-activated protein kinase-dependent phosphorylation of the nuclear estrogen receptor // Endocrinology. 2004. Vol.
145.P. 3265–3272.
34.Hercbergs A. A., Goyal L. K., Suh J. H., Lee S., Reddy C. A., Cohen B. H., Stevens G. H., Reddy S. K., Peereboom D. M., Elson P. J., Gupta M. K., Barnett G. H. Propylthiouracil-induced chemical hypothyroidism with high-dose tamoxifen prolongs survival in recurrent high grade glioma: a Phase I/II study // Anticancer Res. 2003. Vol. 23. P. 617–626.
35.Шабалов Н. П. ред. Неонатология: Учебное пособие в 2 т. Т. II. М.: МЕДпресс-информ, 2004. 640 с.
36.Секреты неонатологии и перинатологии / Полин Ричард А., Спитцер Алан Р. М.: Бином, 2011. 624 с.
37.Feingold S. B., Brown R. S. Neonatal Thyroid Function // NeoReviews. 2010. Vol. 11, N 1. P. 640–646.
38.Patel J., Landers K., Li H., Mortimer R. H., Richard1 K. Thyroid hormones and fetal neurological development // J. Endocrinol. 2011. Vol. 209. P. 1–8.
39.Фадеев В. В., Мельниченко Г. А. Йоддефицитные заболевания и беременность // Рус. мед. журн. 1999. № 7. P. 40–42.
40.Forghani N., Aye T. Hypothyroxinemia and Prematurity // NeoReviews. 2008. Vol. 9, N 2. P. 66–71.
41.Warner A., Mittag J. Thyroid hormone and the central control of homeostasis // J. Mol. Endocrinol. 2012. Vol. 49. P. 29–35.
42.Bernal J. Thyroid hormone receptors in brain development and function. Nature Clinical Practice // Endocrinology & Metabolism. 2007. Vol. 3. P. 249–259.
43.Hernandez A., Martinez M. E., Liao X. H., Van Sande J., Refetoff S., St Galton V. A. Germain D. L. Type
3deiodinase deficiency results in functional abnormalities at multiple levels of the thyroid axis // Endocrinology. 2007. Vol. 148. P. 5680–5687.
44.Shih J. L., Agus M. S. Thyroid function in the critically ill newborn and child // Curr. Opin. Pediatr. 2009. Vol. 21. P. 536–540.
45.Hernandez A., Martinez M. E., Fiering S., Galton V. A., St Germain D. Type 3 deiodinase is critical for the maturation and function of the thyroid axis // Journal of Clinical Investigation. 2006. Vol. 116. P. 476–484.
46.Klein R. Z., Carlton E. L., Faix J. D. et al. Thyroid function in very low birth weight infants // Clin. Endocrinol. (Oxf). 1997. Vol. 47. P. 411–417.
47.Mandel S. J., Hermos R. J., Larson C. A., Prigozhin A. B., Rojas D. A., Mitchell M. L. Atypical hypothyroidism and the very low birthweight infant // Thyroid. 2000. Vol. 10, N 8. P. 693–695.
48.Williams F. L., Simpson J., Delahunty C. et al. Developmental trends in cord and postpartum serum thyroid hormones in preterm infants // J. Clin. Endocrinol. Metab. 2004. Vol. 89. P. 5314–5320.
49.Van Wassenaer A. G., Kok J. H. Hypothyroxinaemia and thyroid function after preterm birth // Seminars in Neonatology. 2004. Vol. 9. P. 3–11.
50.Fisher D. A. Congenital Hypothyroidism. Thyroid international 3–2002 (перевод Фадеева В. В.). http://www.thyronet.ru/spetsialistam/zhurnal/archiv/2002g/4/Vrojdennyi_gipotireoz.html
51.Ogilvy-Stuart A. L. Neonatal thyroid disorders // Arch. Dis. Child. Fetal. Neonatal. Ed. 2002. Vol. 87. P. 165–171.
52.Bernal J., Nunez J. Thyroid hormones and brain development // European Journal of Endocrinology. 1995. Vol. 133. P. 390–398.
53.Fisher D. A. Thyroid system immaturities in very low birth weight premature infants // Seminars in Perinatology. 2008. Vol. 32. P. 387–397.
54.Hume R., Simpson J., Delahunty C., et al. Human fetal and cord serum thyroid hormones: developmental trends and interrelationships // Journal of Clinical Endocrinology & Metabolism. 2004. Vol. 89. P. 4097– 4103.
55.Rapaport R., Rose S. R., Freemark M. Hypothroxinaemia in the preterm infant: the benefits and risks of thyroxine treatment // J. Pediatr. 2001. Vol. 139. P. 182–188.
56.Van Wassenaer A. G., Kok J. H. Thyroid function and thyroid hormone requirements of very preterm infants // NeoReviews. 2000. Vol. 1. P. 116–120.
57.Vanhole C., Aerssens P., Naulaers G. et al. L thyroxine treatment of preterm newborns: clinical and endocrine effects // Pediatr Res. 1997. Vol. 42. P. 87–92.
58.Osborn D. A. Thyroid hormone for preventing of neurodevelopmental impairment in preterm infants // Cochrane Database Syst Rev. 2000; 2: 1–45 CD001070.
59.Williams F. L., Ogston S. A., van Toor H. et al. Serum thyroid hormones in preterm infants: associations with postnatal illnesses and drug usage // J Clin Endocrinol Metab. 2005. Vol. 90. P. 5954–5963.
60.Kilby M. D., Gittoes N., McCabe C., et al. Expression of thyroid receptor isoforms in the human fetal central nervous system and the effects of intrauterine growth restriction // Clinical. Endocrinology. 2000. Vol. 53, N 4. P. 469–477.
61.Golombek S. G. Nothyroidal illness syndrome and euthyroid sick syndrome in intensive care patients // Seminars in Perinatologoy. 2008. Vol. 32. P. 413–418.
62.Ottaway C. A., Fong I. W., da Silva B., Singer W., Karrass L. Integrative aspects of a human model of endotoxemia // Can. J. Physiol. Pharmacol. 1998. Vol. 76, N 5. P. 473–478.
63.Annane D., Bellissant E., Bollaert P. E., Briegel J., Confalonieri M., De Gaudio R., Keh D., Kupfer Y., Oppert M., Meduri G. U. Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review // JAMA. 2009. Vol. 301, N 22. P. 2362–2375.
64.Malay M. B., Ashton R. C. Jr., Landry D. W., Townsend R. N. Low-dose vasopressin in the treatment of vasodilatory septic shock // J. Trauma. 1999. Vol. 47, N 4. P. 699–703.
65.Dellinger R. P., Carlet J. M., Masur H., Gerlach H., Calandra T., Cohen J., Gea-Banacloche J., Keh D., Marshall J. C., Parker M. M., Ramsay G., Zimmerman J. L., Vincent J. L., Levy M. M. Surviving Sepsis Campaign Management Guidelines Committee. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock // Crit. Care. Med. 2004. Vol. 32, N 3. P. 858–873.
66.Mönig H., Arendt T., Meyer M., Kloehn S., Bewig B. Activation of the hypothalamo-pituitary-adrenal axis in response to septic or non-septic diseases — implications for the euthyroid sick syndrome // Intensive Care Med. 1999. Vol. 25, N 12. P. 1402–1406.
67.Schilling J. U., Zimmermann T., Albrecht S., Zwipp H., Saeger H. D. [Low T3 syndrome in multiple trauma patients — a phenomenon or important pathogenetic factor?] // Med. Klin. (Munich). 1999. Vol. 94, Suppl. 3. P. 66–69.
68.Defalque D., Brandt N., Ketelslegers J. M., Thissen J. P. GH insensitivity induced by endotoxin injection is associated with decreased liver GH receptors // Am. J. Physiol. 1999. Vol. 276, N 3, Pt 1. P. E565–E572.
69.Sam A. D. 2nd, Sharma A. C., Lee L. Y., Hales D. B., Law W. R., Ferguson J. L., Bosmann H. B. Sepsis produces depression of testosterone and steroidogenic acute regulatory (StAR) protein // Shock. 1999. Vol. 11, N 4. P. 298–301.
70.Lind L., Carlstedt F., Rastad J., Stiernström H., Stridsberg M., Ljunggren O., Wide L., Larsson A., Hellman P., Ljunghall S. Hypocalcemia and parathyroid hormone secretion in critically ill patients // Crit. Care. Med. 2000. Vol. 28, N 1. P. 93–99.
71.Galton V. A. The roles of the iodothyronine deiodinases in mammalian development // Thyroid. 2005. Vol.
15.P. 823–834.
72.Simic N., Rovet J. Transient Hypothyroxinemia of Prematurity: Current State of Knowledge. Thyroid International 3 2010. http://www.thyrolink.com/en/for_professionals/literature/thyroid_international/ volume_2010/volume_3.html.
73.Paul D. A., Leef K. H., Stefano J. L. Low serum thyroxine on initial newborn screening is associated with intraventricular hemorrhage and death in very low birth weight infants // Pediatrics. 1998. Vol. 101. P. 903–907.
74.Hadeed A. J., Asay L. K., Klein A. H., Fisher D. A. Significance of transient postnatal hypothyroxinemia in premature infants with and without respiratory distress syndrome // Pediatrics. 1981. Vol. 68. P. 494–498.
75.Barker P. M., Walter D. V., Markiewicz M., Strang L. B. Development of the lung liquid resorptive mechanism in fetal sheep. Syndergism of triiodothyronine and hyrocortisone // Journal of Physiology. 1991. Vol. 433. P. 435–449.
76.Klein I., Ijamaa K. Thyroid hormone and the cardiovascular system // New Engl. J. Med. 2001. Vol. 344. P. 501–509.
77.Portman M. A. Thyroid hormone regulation of perinatal cardiovascular function // Seminars in Perinatologoy. 2008. Vol. 32. P. 419–422.
78.Nagawena T. Delayed closure of ductus arte-riosus in premature infants with transient hy-pothyroidism // Lancet. 1993. Vol. 341. P. 839.
79.Lima F. R., Gervais A., Colin C., Izembart M., Neto V. M., Mallat M. Regulation of microglial development: a novel role for thyroid hormone // J. Neurosci. 2000. Vol. 21, N 6. P. 2028–2038.
80.Ferreira A. A., Pereira M. J., Manhães A. C., Barra-das P. C. Ultrastructural identification of oligodendrocyte/myelin proteins in corpus callo-sum of hypothyroid animals // Int. J. Devl Neuro-science. 2007. Vol. 25. P. 87–94.
81.Den Ouden A. L., Kok J. H., Verkerk P. H. et al. The relation between neonatal thyroxine levels and neurodevelopmental outcome at age 5 and 9 years in a national cohort of very preterm and/or very low birth weight infants // Pediatric Research. 1996. Vol. 39. P. 142–145.
82.Schellenber J. C., Liggins G. C. New approaches to hormonal acceleration of fetal lung maturation // Journal of Pernatal Medicine. 1987. Vol. 15. P. 447–452.
83.Morreale de Escobar G., Ares S. et al. The changing role of maternal thyroid hormone in fetal brain development // Seminars in Perinatology. 2008. Vol. 32. P. 380–386.
84.Hong T., Paneth N. Maternal and infant thyroid disorders and cerebral palsy // Semin. Perinatol. 2008. Vol.
32.P. 438–445.
85.Rastogi M. V., LaFranchi S. H. Congenital hypothyroidism // Orphanet Journal of Rare Diseases. 2010. Vol. 5. P. 17.
86.van Wassenaer A. G., Westera J., Houtzager B. A., Kok J. H. Ten-year follow-up of children born at <30 weeks’ gestational age supplemented with thyroxine in the neonatal period in a randomized, controlled trial
//New England Journal of Medicine. 2005. Vol. 336, N 1. P. 21–26.
87.Crowther C. A., Hiller J. E., Haslam R. R. et al. Australian collaborative trial of antenatal thyrotopinreleasing hormone: adverse effects at 12 month follow-up // Pediatrics. 1997. Vol. 99. P. 311–317.
88.van Wassenaer A. G, Kok J. H. Trials with thyroid hormone in preterm infants: Clinical and neurodevelopmental effects // Seminars in Perinatology. 2008. Vol. 32. P. 423–430.
89.Chowdhry P., Scanlon J. W., Auerbach R., Abbassi V. Results of controlled double-blind study of thyroid replacement in very low-birth-weight premature infants with hypothyroxinemia // Pediatrics. 1984. Vol. 73. P. 301–305.
90.La Gamma E. F., van Wassenaer A. G., Golombek S. G., et al. Neonatal thyroxine supplementation for transient hypothyrxinemia of prematurity (THOP): Beneficial or detrimental? // Treat Endocrinol. 2006. Vol. 5. P. 335–346.
91.Ng S. M., Turner M. A., Gamble C. et al. TIPIT: A randomised controlled trial of thyroxine in pre-term infants under 28 weeks’ gestation // Trials. 2008. Vol. 9. P. 1–13.
92.Golombek S. G., LaGamma E. F., Paneth N. Treatment of transient hypothyroxinemia of prematurity: a survey of neonatal practice // Journal of Perinatology. 2003. Vol. 22. P. 563–565.
93.Williams F. L. R., Hume R. Perinatal factors affecting tyroid hormone status in extreme preterm infants // Semin. Perinatol. 2008. Vol. 32. P. 398–402.
94.Asztalos E. V. Thyroid hormone supplementation in preterm infants. Ontario: Hamilton, M.Sc., McMaster University, 2002.
95.Huang S. A., Tu H. M., Harney J. W., Venihaki M., Butte A. J., Kozakewich H. P. W., Fishman S. J., Reed Larsen P. Severe Hypothyroidism Caused by Type 3 Iodothyronine Deiodinase in Infantile Hemangiomas
//N. Engl. J. Med. 2000. Vol. 343. P. 185–189.
96.La Franchi S. H. Hypothyroidism, Congenital and Acquired // Clinical Pediatric and Adolescent Endocrinology / S. A. Kaplan (ed). Philadelphia: Saunders, 1982. P. 87, and Nichol’s Institute normal reference range.
97.Briёt J. M., van Wassenaer A. G., Dekker F. W. et al. Neonatal thyroxine supplementation in very preterm children: developmental outcome evaluated at early school age // Pediatrics. 2001. Vol. 107. P. 712–718.
98.Auso E., Lavado-Autric R., Cuevas E. et al. Moderate and Transient Deficiency of Maternal Thyroid Function at the Beginning of Fetal Neocor-ticogenesis Alters Neuronal Migration // Endocrinology. 2004. Vol. 145, N 9. P. 4037–4047.
99.Counts D., Varma S. K. Hypothyroidism in children // Pediatr. Rev. 2009. Vol. 30, N 7. P. 251–258.
100.Cameo T., Gumer L. B., Williams K. M., Gomez J., McMahon D. J., Oberfield S. E. A retrospective review of newborn screening for congenital hypothyroidism and newborn thyroid disease at a major medical center // Clin. Pediatr. (Phila). 2013. Vol. 52, N 11. P. 1054–1058.
101.Cassio A., Corbetta C., Antonozzi I., Calaciura F., Caruso U., Cesaretti G., Gastaldi R., Medda E., Mosca F., Pasquini E., Salerno M. C., Stoppioni V., Tonacchera M., Weber G., Olivieri A.; Italian Society for Pediatric Endocrinology and Diabetology; Italian Society for the Study of Metabolic Diseases and Neonatal Screening; Italian National Institute of Health; Italian National Coordinating Group for Congenital Hypothyroidism; Italian Thyroid Association; Italian Society of Pediatrics; Italian Society of Neonatology; Italian Society of Endocrinology; Associazione Medici Endocrinologi. The Italian screening program for primary congenital hypothyroidism: actions to improve screening, diagnosis, follow-up, and surveillance // J. Endocrinol. Invest. 2013. Vol. 36, N 3. P. 195–203.
102.Alm J., Larsson A., Westphal O. [A program for the nation-wide screening of newborn infants for congenital hypothyreosis] // Lakartidningen. 1980. Vol. 77, N 35. P. 2884–2886.
103.Ares S., Quero J., de Escobar G. M. Iodine balance, iatrogenic excess, and thyroid dysfunction in premature newborns // Semin. Perinatol. 2008. Vol. 32. P. 407–412.
104.Bamforth J. S., Hughes I., Lazarus J., John R. Congenital anomalies associated with hypothyroidism // Arch. Dis. Child. 1986. Vol. 61, N 6. P. 608–609.
105.Borrajo G. J. Newborn screening in Latin America at the beginning of the 21st century // J. Inherit. Metab. Dis. 2007. Vol. 30. P. 466–481.
106.Bellman S. C., Davies A., Fuggle P. W., Grant D. B., Smith I. Mild impairment of neuro-otological function in early treated congenital hypothyroidism // Arch. Dis. Child. 1996. Vol. 74, N 3. P. 215–218.
107.Berbel P., Guadano-Ferraz A., Angulo A. et al. Role of thyroid hormones in the maturation of interhemispheric connections in rats // Behavioural Brain Research. 1994. Vol. 64, N 1–2. P. 9–14.
108.Диагностика и лечение эндокринных заболеваний у детей и подростков. Учебн. пособие / Под ред. проф. Н. П. Шабалова. 2-е изд. М., 2009. 346 с.
109.Шерешевский Н. А. Клиническая эндокринология. М., 1957.
110.Adeniran K. A., Limbe M. Review Article on Congenital Hypothyroidism and Newborn Screening Program in Africa; the Present Situation and the Way Forward // J. Thyroid. Disord. 2012. Ther 1:102.